We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14.8B
AUM Growth
+$1.41B
Cap. Flow
-$396M
Cap. Flow %
-2.67%
Top 10 Hldgs %
34.28%
Holding
1,311
New
31
Increased
615
Reduced
268
Closed
37

Sector Composition

Rank Sector Weight
1 Real Estate 59.19%
2 Technology 7.88%
3 Communication Services 4.43%
4 Consumer Discretionary 3.51%
5 Financials 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACET icon
1151
Adicet Bio
ACET
$74.7M
$1K ﹤0.01%
4
ACIU icon
1152
AC Immune
ACIU
$234M
$1K ﹤0.01%
158
ADAP
1153
DELISTED
Adaptimmune Therapeutics
ADAP
$1K ﹤0.01%
256
ADVM
1154
DELISTED
Adverum Biotechnologies
ADVM
$1K ﹤0.01%
18
AKBA icon
1155
Akebia Therapeutics
AKBA
$343M
$1K ﹤0.01%
316
ALT icon
1156
Altimmune
ALT
$576M
$1K ﹤0.01%
62
ANIP icon
1157
ANI Pharmaceuticals
ANIP
$1.78B
$1K ﹤0.01%
27
APLT
1158
DELISTED
Applied Therapeutics
APLT
$1K ﹤0.01%
42
ARDX icon
1159
Ardelyx
ARDX
$1.27B
$1K ﹤0.01%
196
AVDL
1160
DELISTED
Avadel Pharmaceuticals
AVDL
$1K ﹤0.01%
120
BDTX icon
1161
Black Diamond Therapeutics
BDTX
$102M
$1K ﹤0.01%
68
CGEN icon
1162
Compugen
CGEN
$225M
$1K ﹤0.01%
156
CLLS
1163
Cellectis
CLLS
$286M
$1K ﹤0.01%
40
CRNX icon
1164
Crinetics Pharmaceuticals
CRNX
$8.87B
$1K ﹤0.01%
62
CTMX icon
1165
CytomX Therapeutics
CTMX
$740M
$1K ﹤0.01%
102
DNTH icon
1166
Dianthus Therapeutics
DNTH
$5.76B
$1K ﹤0.01%
7
DTIL icon
1167
Precision BioSciences
DTIL
$194M
$1K ﹤0.01%
4
ESPR
1168
DELISTED
Esperion Therapeutics
ESPR
$1K ﹤0.01%
52
FULC icon
1169
Fulcrum Therapeutics
FULC
$249M
$1K ﹤0.01%
52
GERN icon
1170
Geron
GERN
$956M
$1K ﹤0.01%
684
LKFT
1171
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$1K ﹤0.01%
13
GOSS icon
1172
Gossamer Bio
GOSS
$93.5M
$1K ﹤0.01%
143
IDYA icon
1173
IDEAYA Biosciences
IDYA
$3.48B
$1K ﹤0.01%
55
INZY
1174
DELISTED
Inozyme Pharma
INZY
$1K ﹤0.01%
44
KALA icon
1175
KALA BIO
KALA
$12.3M
0

Similar funds

Daiwa Securities Group's Q2 2021 Portfolio in Review

As of Q2 2021, Daiwa Securities Group held 1,311 positions worth $14.8B, up 10% from $13.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group's Q2 2021 filing shows 31 new, 615 increased, 268 reduced and 37 closed positions. Its largest new stake was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M. The largest sale was Invitation Homes, an estimated $172M.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, down from 61% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q2 2021 buy was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M.
  • Daiwa Securities Group added most to AvalonBay Communities in Q2 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q2 2021 reduction was Invitation Homes, cutting an estimated $172M.
  • Daiwa Securities Group fully exited Global X Cloud Computing ETF in Q2 2021, selling an estimated $29.5M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $14.8B portfolio in Q2 2021.
  • Daiwa Securities Group opened 31 new positions and closed 37 in Q2 2021.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $14.8B.

Based on Daiwa Securities Group's 13F filing for Q2 2021, filed 6 Aug 2021.